Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.

[1]  F. Turnbull,et al.  Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes , 2007, Heart.

[2]  F. Werf.  Dual antiplatelet therapy in high-risk patients , 2007 .

[3]  C. Collins,et al.  Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003 , 2007, BMC Health Services Research.

[4]  G. Filippatos,et al.  The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. , 2006, European heart journal.

[5]  K. Fox.  Registries and surveys in acute coronary syndrome. , 2006, European heart journal.

[6]  L. Køber,et al.  Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. , 2006, European heart journal.

[7]  K. Eagle,et al.  Adherence to Medications by Patients After Acute Coronary Syndromes , 2005, The Annals of pharmacotherapy.

[8]  Á. Avezum,et al.  Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). , 2003, American heart journal.

[9]  M. Olfson,et al.  Medication costs, adherence, and health outcomes among Medicare beneficiaries. , 2003, Health affairs.

[10]  N J Wald,et al.  A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.

[11]  K. Eagle,et al.  Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). , 2002, The American journal of cardiology.

[12]  R. Beaglehole.  Global cardiovascular disease prevention: time to get serious , 2001, The Lancet.

[13]  Jing Liu,et al.  Sino-MONICA Project: A Collaborative Study on Trends and Determinants in Cardiovascular Diseases in China, Part I: Morbidity and Mortality Monitoring , 2001, Circulation.

[14]  C B Granger,et al.  Risk stratification and therapeutic decision making in acute coronary syndromes. , 2000, JAMA.